Timber Pharmaceuticals Inc (NYSE American:TMBR)

0.97
Delayed Data
As of Oct 30
 -0.04 / -3.96%
Today’s Change
0.87
Today|||52-Week Range
12.60
-80.94%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$12.9M

Company Description

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex and localized scleroderma. The company is headquartered in Woodcliff Lake, NJ.

Contact Information

Timber Pharmaceuticals, Inc.
50 Tice Boulevard
Woodcliff Lake New Jersey 07677
P:(973) 314-9570
Investor Relations:

Employees

Shareholders

Individual stakeholders45.19%
Other institutional20.13%
Mutual fund holders0.10%

Top Executives

John KoconisChief Executive Officer & Director
Zachary RomeChief Operating Officer, Secretary & Executive VP
Joseph LuccheseChief Financial Officer & Executive Vice President
Amir TavakkolChief Scientific Officer